Logo image of GCTS

GCT SEMICONDUCTOR HOLDING IN (GCTS) Stock Fundamental Analysis

NYSE:GCTS - New York Stock Exchange, Inc. - US36170N1072 - Common Stock - Currency: USD

1.35  -0.12 (-8.16%)

Premarket: 1.44 +0.09 (+6.67%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to GCTS. GCTS was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of GCTS have multiple concerns. GCTS is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year GCTS has reported negative net income.
In the past year GCTS has reported a negative cash flow from operations.
GCTS Yearly Net Income VS EBIT VS OCF VS FCFGCTS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 10M -10M 20M -20M -30M

1.2 Ratios

GCTS has a worse Return On Assets (-115.04%) than 94.55% of its industry peers.
Industry RankSector Rank
ROA -115.04%
ROE N/A
ROIC N/A
ROA(3y)-64.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
GCTS Yearly ROA, ROE, ROICGCTS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 50 -50 -100

1.3 Margins

The Gross Margin of GCTS (50.50%) is better than 62.73% of its industry peers.
GCTS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GCTS Yearly Profit, Operating, Gross MarginsGCTS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -100 -200

More info and screens

0

2. Health

2.1 Basic Checks

GCTS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GCTS has been increased compared to 1 year ago.
Compared to 1 year ago, GCTS has an improved debt to assets ratio.
GCTS Yearly Shares OutstandingGCTS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 10M 20M 30M 40M
GCTS Yearly Total Debt VS Total AssetsGCTS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

Based on the Altman-Z score of -53.68, we must say that GCTS is in the distress zone and has some risk of bankruptcy.
GCTS has a worse Altman-Z score (-53.68) than 87.27% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -53.68
ROIC/WACCN/A
WACC10.61%
GCTS Yearly LT Debt VS Equity VS FCFGCTS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 100M -100M 200M 300M

2.3 Liquidity

A Current Ratio of 0.22 indicates that GCTS may have some problems paying its short term obligations.
GCTS has a Current ratio of 0.22. This is amonst the worse of the industry: GCTS underperforms 98.18% of its industry peers.
A Quick Ratio of 0.17 indicates that GCTS may have some problems paying its short term obligations.
GCTS has a Quick ratio of 0.17. This is amonst the worse of the industry: GCTS underperforms 98.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.22
Quick Ratio 0.17
GCTS Yearly Current Assets VS Current LiabilitesGCTS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

GCTS shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -41.32%.
GCTS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -14.69%.
EPS 1Y (TTM)-41.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-951.16%
Revenue 1Y (TTM)-14.69%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-84.81%

3.2 Future

Based on estimates for the next years, GCTS will show a very strong growth in Earnings Per Share. The EPS will grow by 42.60% on average per year.
GCTS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 135.34% yearly.
EPS Next Y16.67%
EPS Next 2Y59.16%
EPS Next 3Y42.6%
EPS Next 5YN/A
Revenue Next Year122.97%
Revenue Next 2Y215.83%
Revenue Next 3Y135.34%
Revenue Next 5YN/A

3.3 Evolution

GCTS Yearly Revenue VS EstimatesGCTS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 20M 40M 60M 80M 100M
GCTS Yearly EPS VS EstimatesGCTS Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 0.1 -0.1 0.2 -0.2 -0.3

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GCTS. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 8.27, the valuation of GCTS can be described as reasonable.
Based on the Price/Forward Earnings ratio, GCTS is valued cheaper than 95.45% of the companies in the same industry.
GCTS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 8.27
GCTS Price Earnings VS Forward Price EarningsGCTS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GCTS Per share dataGCTS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

GCTS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GCTS's earnings are expected to grow with 42.60% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.16%
EPS Next 3Y42.6%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for GCTS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GCT SEMICONDUCTOR HOLDING IN

NYSE:GCTS (6/17/2025, 8:04:01 PM)

Premarket: 1.44 +0.09 (+6.67%)

1.35

-0.12 (-8.16%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)05-14 2025-05-14/amc
Earnings (Next)08-12 2025-08-12
Inst Owners13.54%
Inst Owner Change12.55%
Ins Owners3.56%
Ins Owner Change-23.89%
Market Cap75.29M
Analysts82.86
Price Target4.59 (240%)
Short Float %2.46%
Short Ratio1.62
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-9.48%
Min EPS beat(2)-47.06%
Max EPS beat(2)28.1%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-43.95%
Min Revenue beat(2)-74.04%
Max Revenue beat(2)-13.85%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-10%
EPS NQ rev (1m)-27.27%
EPS NQ rev (3m)12.5%
EPS NY rev (1m)0%
EPS NY rev (3m)40.48%
Revenue NQ rev (1m)-28.12%
Revenue NQ rev (3m)-74.26%
Revenue NY rev (1m)-43.78%
Revenue NY rev (3m)-60.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.27
P/S 11.84
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)0.16
Fwd EY12.09%
FCF(TTM)-0.45
FCFYN/A
OCF(TTM)-0.44
OCFYN/A
SpS0.11
BVpS-1.18
TBVpS-1.18
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -115.04%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.5%
FCFM N/A
ROA(3y)-64.06%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 51.4%
Cap/Sales 10.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.22
Quick Ratio 0.17
Altman-Z -53.68
F-Score2
WACC10.61%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-41.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-951.16%
EPS Next Y16.67%
EPS Next 2Y59.16%
EPS Next 3Y42.6%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.69%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-84.81%
Revenue Next Year122.97%
Revenue Next 2Y215.83%
Revenue Next 3Y135.34%
Revenue Next 5YN/A
EBIT growth 1Y-80.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year26.42%
EBIT Next 3Y50.09%
EBIT Next 5YN/A
FCF growth 1Y-1928.63%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1875.4%
OCF growth 3YN/A
OCF growth 5YN/A